Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922986 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01922986 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 4 participants.
The verdict
NCT01922986, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
When a certain area of the brain is injured, like in stroke, several events occur. One side of the body may become weak. This weakness is called hemiparesis and it may create difficulty in performing tasks like writing, eating, and walking. The weakness results from two sources: 1. death of some brain cells in the affected side (hemisphere) of the brain 2. exaggerated inhibitory signals from the unaffected hemisphere acting on surviving neurons in the affected hemisphere. Investigators cannot change neurons that have died but they may be able to change the exaggerated inhibition that impairs the surviving neurons in the affected hemisphere.The purpose of this study is to try to decrease the exaggerated inhibition coming from the unaffected hemisphere, which suppresses the affected hemisphere, with transcranial magnetic stimulation (TMS). Investigators hypothesize that, from admission to discharge, active rTMS combined with conventional therapy will produce greater functional gains in the paretic hand compared to sham rTMS combined with conventional therapy, as measured by standard tests.
Interventions
- DEVICE sham rTMS
- DEVICE active rTMS
- BEHAVIORAL conventional stroke therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01922986
The ClinicalTrials.gov registry entry for NCT01922986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which sham rTMS is the first listed.
NCT01922986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01922986 about?
NCT01922986 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke". When a certain area of the brain is injured, like in stroke, several events occur. One side of the body may become weak. This weakness is called hemiparesis and it may create difficulty in performing tasks like writing, eating, and walking. The weakness results from two sources: 1. death of some br...
What is the current status of trial NCT01922986?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2013-09. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01922986?
The interventions under investigation include: sham rTMS (DEVICE), active rTMS (DEVICE), conventional stroke therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01922986?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.